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Background: Awareness represents a major modulator for the uptake of preventive measures and healthy life-style
choices. Women underestimate the role of cardiovascular diseases as causes of mortality, yet little information is
available about their subjective risk awareness.
Methods: The Berlin Female Risk Evaluation (BEFRI) study included a randomized urban female sample aged 25–74 years,
in which 1,066 women completed standardized questionnaires and attended an extensive clinical examination. Subjective
estimation was measured by a 3-point Likert scale question asking about subjective perception of absolute cardiovascular
risk with a 10 year outlook to be matched to the cardiovascular risk estimate according to the Framingham score for
women.
Results: An expected linear increase with age was observed for hypertension, hyperlipidemia, obesity, and vascular
compliance measured by pulse pressure. Knowledge about optimal values of selected cardiovascular risk factor indicators
increased with age, but not the perception of the importance of age itself. Only 41.35% of all the participants correctly
classified their own cardiovascular risk, while 48.65% underestimated it, and age resulted as the most significant predictor
for this subjective underestimation (OR = 3.5 for age >50 years compared to <50, 95% CI = 2.6–4.8, P <0.0001). Therefore,
although socioeconomic factors such as joblessness (OR = 1.9, 95% CI = 1.4–2.6, P <0.0001) and combinations of other
social risk factors (low income, limited education, simple job, living alone, having children, statutory health coverage only;
OR = 1.5, 95% CI = 1.1–2.1, P = 0.009) also significantly influenced self-awareness, age appeared as the strongest predictor
of risk underestimation and at the same time the least perceived cardiovascular risk factor.
Conclusions: Less than half of the women in our study population correctly estimated their cardiovascular risk. The study
identifies age as the strongest predictor of risk underestimation in urban women and at the same time as the least
subjectively perceived cardiovascular risk factor. Although age itself cannot be modified, our data highlights the need for
more explicit risk counseling and information campaigns about the cardiovascular relevance of aging while focusing on
measures to control coexisting modifiable risk factors.
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Cardiovascular diseases represent the primary cause of
mortality for women worldwide and their relevance is pro-
jected to increase significantly in upcoming years. These
diseases are not only major causes of mortality, but also in-
creasingly relevant as causes of long-term disability given
the progressive improvement of medical care. In fact, the
World Health Organization predicts that, in 2030, the
disability related to ischemic heart disease and cerebrovas-
cular disease will amount to 9.8% of all disability-adjusted
life years worldwide [1]. Many large clinical studies have
proven the partial preventability of cardiovascular disease
with lifestyle measures, such as smoking cessation [2],
healthy eating [3,4], physical activity [5], and weight [6] and
stress management [7]. Active risk reduction becomes in-
creasingly relevant as the individual ages; since ageing rep-
resents one of the most relevant uncontrollable risk factors
the general population is exposed to [8]. Even though the
importance of cardiovascular disease for women is well
documented, subjective awareness is limited [9]. Informa-
tion campaigns such as the American Heart Association’s
“go red for women” have proven partially effective in raising
awareness in the female population in the United States
[10], yet similar actions have not been implemented in
Europe. Small studies in the German female population
provide evidence for an analogous underestimation of car-
diovascular risk in favor of breast cancer as the primary
cause of mortality for women [11].
While these studies document the underestimation of
the objective role of cardiovascular diseases as causes of
mortality, the role of underestimation of one’s subjective
cardiovascular risk has never been documented in the
female population. With regards to targeted prevention,
however, self-perception of risk and risk awareness rep-
resent indisputable steps for uptake. In fact, underesti-
mation of risk has not only been linked to an increase in
risky behavior [12], it is also believed to be associated
with the limited uptake of preventive offers [13]. Thus,
improvement of self-awareness might represent an es-
sential step to increase commitment to prevention and
healthy life-style choices.
This study was designed to identify predictors of in-
correct subjective risk estimation in the general female
urban population in Germany, with the aim to pinpoint




The Berlin Female Risk Evaluation (BEFRI) study was
designed to appropriately represent the city’s population
(Additional file 1: Table S1). The city of Berlin is divided
into 12 boroughs with different social structure and dif-
ferent population density. We aimed to obtain a studypopulation of 1,000 women that could appropriately repre-
sent the city’s population. Thus, in accordance with re-
sponse rates of about 30 to 40% in German studies with
more complex recruiting strategies [14], we envisioned a re-
sponse rate between 20 and 30% for our strategy and in-
vited 3,600 women to participate. Women were randomly
selected by the city census (Einwohnermeldeamt). Inclusion
criteria were age between 25 and 74 years, represented in
five equal age strata, and proportional representation of the
boroughs inhabitant density, i.e., densely populated bor-
oughs contributed more participants than scarcely popu-
lated ones.
Randomized women were sent a single invitation letter
and one reminder by regular mail describing the study’s
purpose and the exams to be conducted in case of accept-
ance. If women wanted to participate or obtain more in-
formation before consenting, they were advised to notify
the study coordination center by phone, mail, or e-mail.
All women who expressed the intention to participate
(n = 1,199) were sent the questionnaire, consent forms,
and further information materials by mail and an appoint-
ment was scheduled, if requested. Of these 1,066 (88.9%)
agreed to participate; 3 of these women were excluded
from analysis because they had reached age 75 by the time
they attended the appointment and 1 due to major literacy
issues demonstrated upon clinical interview. We com-
pared social indicators within our population with the
census data of the city of Berlin (reference sample) and
cardiovascular risk factor prevalence with German na-
tional data (Additional file 1: Table S1) confirming a valid
representation of the city’s population structure and risk
factor distribution. Once women agreed to participate, ap-
pointments were scheduled either at Charité hospital or
externally at the borough level based on the participants’
preference.
Examinations
At the appointment, written informed consent was ob-
tained, a standardized medical history was taken, and clin-
ical examinations were performed. Data was collected in
paper form and recorded using an Access (Microsoft Corp.,
Seattle, WA, USA) database for management during the re-
cruitment period. All patient data was pseudonymized at
the collection site using serial numbers. Participants were
first asked if any items within the questionnaires needed
clarification and, if needed, further information was given
for unclear questions. Medical history focusing on the pres-
ence of common risk factors, history of previous diseases,
and specific cardiovascular symptoms and manifestations
was taken. Previous and current hormone therapy, as well
as current medication use was also recorded. Clinical exam-
inations were then performed. All women were weighed
lightly clothed on a standard Bosch scale (Axxence Spirit,
Bosch GmbH, Stuttgart, Germany) to the nearest 0.1 kg,
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(Seca 216, Hamburg, Germany) whilst standing com-
pletely erect without shoes. Waist and hip circumference
were determined with a non-stretchable standard tape
measure placed straight at the narrowest level at the waist
between the costal margin and iliac crest and hip circum-
ference at the largest level across the buttocks. Women
were then asked to lie down for electrocardiogram (ECG),
blood pressure, and arterial stiffness measurements. A 12-
lead ECG was performed following the standardized
procedure (AT-10plus, Schiller, Baar, Switzerland). Meas-
urement of blood pressure on both arms and legs and of
vascular stiffness parameters were obtained after at least
10 minutes rest with an Arteriograph device (TensioMed
Ltd., Budapest, Hungary). Venipuncture was performed
lying down or in an upright position based on the
participant’s preference with a Monovette (Sarstedt AG,
Nümbrecht, Germany) system. Blood was collected in eth-
ylenediaminetetraacetic acid and citrate tubes and placed
immediately into a refrigerator at 4°C until collection. All
samples were transferred to the processing lab on dried ice
or cool packs the same day and processed within 24 hours
from collection. Full blood counts, renal function, lipid
metabolism, glycated haemoglobin, b-type natriuretic pep-
tide, and sexual hormones were determined at an external
lab (Hospital Laborverbund Berlin-Brandenburg, Bernau,
Germany). Diagnoses of hypertension and diabetes were
based on internationally accepted criteria [15,16]. Auto-
immune diseases were classified according to the American
College of Rheumatology guidelines. Upon completion of
the examination, participants obtained a reimbursement of
50 Euros. In order to minimize selection bias, information
about the compensation was only given once women had
agreed to participate. The institutional ethics committee
approved the study (Ethikkommission, internal identifica-
tion number EA2/116/12) and all research conforms to the
Declaration of Helsinki.
Questionnaires
All participants were sent a specifically designed question-
naire to assess several domains: sociodemography, clinical
and family history, gynecological anamnesis, physical fit-
ness, prevention history, and psychosocial dimensions.
Sociodemographic variables were elicited using standard
questions from the German Health Survey ([17] with per-
mission from Robert Koch Institute) or slight modifica-
tions thereof, as well as investigator-designed questions, if
needed. Clinical and family history assessment contained
detailed questions about a large number of cardiovascular
conditions in the family and partner. Participant risk fac-
tors, as well as presence of myocardial infarction, stroke,
thromboembolic events, vascular events, or sudden death
were documented. Gynecological history mostly focused
on physiological events and pregnancy complications, aswell as previous or current hormone therapy. Physical work
capacity was determined using the Duke Activity Status
Index score [18]. Subjective risk was determined by a direct
question about subjective estimation of absolute cardiovas-
cular risk with a 10-year outlook using a 3-point Likert
scale answer option (low, medium, high). The question was
embedded in a set of questions about risk perception, intro-
duced by a description of the nature of cardiovascular
disease and its potential outcomes, such as myocardial in-
farction or stroke. Prevention history and expectations were
elicited with specifically designed questions. General health
perception and quality of life was elicited using the SF-12,
the short form of the SF-36 questionnaire [19]. Social sup-
port, depression, and exposure to critical life events were
tested using standardized measures [20]. The full question-
naire was piloted in a set of 50 women of different age and
socioeconomic and educational level to test feasibility, dur-
ation, and comprehension. Single questions were adapted
based on piloting results. Average completion time was
75 minutes.
Statistical analysis
The main hypothesis to be tested within this study was the
presence of a statistically significant subjective underestima-
tion of cardiovascular risk in the general population. The
secondary aim was the identification of modifying factors
for incorrect estimation of cardiovascular risk. Descriptive
statistics were computed to identify risk factor distributions
within age groups and to allow a comparison of the study
population with the mean demographics of the urban refer-
ence sample. Subjective estimation was correlated with the
three-tiered Framingham global cardiovascular disease risk
score for women [21] to define correctness of estimation.
This score was selected due to its high validation, compared
to QRISK [22] or the Reynolds Risk score [23], which could
have been otherwise valid alternatives, and its ability to rep-
resent the breadth of cardiovascular disease, rather than
focusing on solely coronary heart disease and its acute con-
sequences, which would underestimate risk in women. Fur-
thermore, it will also allow for comparison with a male
study population in the future. Univariate analyses defining
the association of single risk factors with over- or underesti-
mation using correct estimation as the baseline was then
performed. Tests for trend were performed using a non-
parametric Cuzick test for trend, an extension of the
Wilcoxon rank-sum test. Two-tailed analyses were con-
ducted and a P value <0.05 was considered statistically sig-
nificant. Since missing rates for demographic and laboratory
parameters were <3% in the whole dataset, no imputation
was calculated for missing data. Following this, multivariate
logistic models were fitted with under- or overestimation as
outcome variables. Different strategies were employed to as-
certain model robustness. A model using all variables from
the univariate analysis was fitted and reduced progressively
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ables to avoid overfitting. Interaction terms among signifi-
cant variables in the univariate analyses were included,
but proved non-significant. Likelihood ratio tests were
performed at each step to confirm redundancy of the
eliminated variables. This was conducted until no further
reduction was possible. Automated forward and backward
regression models were also calculated and confirmed the
final model. Model misspecification was assessed by the
Wald test and goodness-of-fit by the Hosmer-Lemeshow
test. All statistical analyses were performed using STATA
Version 13 (STATA Corp, College Station, TX, USA).
Results
Sociodemographic characteristics of the study population
The complete study population (n = 1,062) was divided
into five equally-powered age groups (Table 1). Sociode-
mographic descriptors were distributed in accordance
with the reference urban population of the city of Berlin
(Additional file 1: Table S1); 46.1% of the women in the
study population displayed lower educational status with
older women more frequently reporting less years of for-
mal education. In fact, the youngest age stratum was the
only one diverging from the reference sample, with a
higher representation of well-educated women. Further,
61.7% of the women had lower to middle responsibility
and skill jobs and 49.8% reported a family income below
2,000 Euros a month. Income trends are U-shaped with
the highest percentages of low earners among the first
and last age stratum, i.e., below 35 and above 65 years of
age. About one third of the women reported living alone,
with a significant increase with increasing age. Addition-
ally, 70.2% of the women stated that they ever had chil-
dren, with a prevalence of 86.6% in the oldest age
stratum. In accordance with the structure of the German
health care system, no women reported absence of any
form of health insurance; 68% had only statutory insur-
ance coverage, with an increasing trend with age. Most
women had a general practitioner and 69 to 78% re-
ported attending their office at least once during the
3 months prior to the study.
Risk factor distribution with age
We assessed common and female-specific cardiovascular
risk factor prevalence with age (Table 1). As expected, active
smoking prevalence decreased with age while diabetes,
hypertension, hyperlipidemia, obesity, and vascular compli-
ance measured by pulse pressure values demonstrated a lin-
ear increase with age. While none of the women below
34 years of age suffered from diabetes, 13.2% above 65 years
of age did. Hypertension affected more than 50% of the
women in the highest age stratum. Obesity was assessed
with two different criteria, body mass index (BMI) and
waist-to-hip ratio (WHR), to account for the increasedpathologic relevance of abdominal obesity. In fact, while
only 23% of the women above 65 years were classified as
obese according to BMI, 40% displayed abdominal obesity.
Interestingly, women below 34 years displayed a lower
incidence of obesity according to WHR compared to BMI
measurement, while in all other age groups diagnosis
according to WHR proved more stringent. Pregnancy
complications were reported slightly more frequently with
increasing age. The prevalence of depressive symptoms
(Patient Health Questionnaire (PHQ9) ≥10) displayed a
constant prevalence between 16 and 21% throughout all
age groups, but the highest.
Subjective estimation of risk
To determine correctness of self-estimation of risk, we
compared subjectively asserted cardiovascular risk on a 3-
point Likert scale with the objective risk measured accord-
ing to the Framingham risk score for women [21,24]. In
our population, only 41.35% of all the participants correctly
identified their own risk, whereas 48.65% underestimated it
and 10% overestimated it (Table 2). In univariate analysis,
age appeared as the single most predictive factor for under-
estimation with women in the highest age group 13.8 times
more likely to underestimate their risk compared to the
youngest. In univariate analyses, several biological risk fac-
tors were associated with a trend for underestimation of
risk (Additional file 2: Table S2); nevertheless, after adjust-
ment for age and other covariates in the multivariate ana-
lysis, none of these associations was confirmed due to the
strong collinearity with age. Age and social risk factors,
however, proved significant even after adjustment for all
possible confounders. Moreover, age was confirmed as the
single most significant predictor of underestimation with
women over 50 years of age 3.5 times more likely to under-
estimate their risk (odds ratio (OR) = 3.5, 95% confidence
interval (CI) = 2.6–4.8, P <0.0001; Tables 3 and 4). Jobless-
ness, either due to unemployment or retirement, also in-
creased the risk of underestimation by almost 2 times.
Social risk factors were, however, most powerful in combin-
ation. In fact, while low income, limited education, a simple
job, living alone, having children, and having only statutory
coverage were not associated with underestimation taken
singularly, the unfavorable combination of three or more of
these factors increased the risk of underestimation by 1.5
times.
As expected, older age was negatively correlated with
overestimation (OR = 0.45, 95% CI = 0.24–0.87, P = 0.02,
Tables 3 and 4), as were low income and simple to mid-
level employment. Subjective negative rating of the overall
health status was a significant predictor of overestimation
of risk (OR = 2.7, 95% CI = 1.4–5.1, P = 0.002), as were de-
pressive symptoms (PHQ ≥10; OR = 2.2, 95% CI = 1.2–4.0,
P = 0.014). However, while 40.7% of all overestimators re-
ported symptoms compatible with major depression, only














Age (mean) 50.3 (25–75) 30 (25–34) 40.3 (35–44) 49.7 (45–54) 59.4 (55–64) 70 (65–75)
Education (≤10 years) 490 (46.1%) 49 (24.1%) 87 (42.4%) 104 (47.3%) 110 (52.1%) 140 (62.8%)
Profession (low status) 623 (65.9%) 92 (65.9%) 120 (66.3%) 133 (64.9%) 138 (70.8%) 141 (70.9%)
Income (<2,000 Euros/month) 464 (49.8%) 106 (57.3%) 70 (39.1%) 88 (43.6%) 80 (44.4%) 120 (64.5%)
Family situation (living alone) 332 (31.3%) 63 (31%) 36 (17.6%) 55 (25%) 83 (39.3%) 95 (42.6%)
Parity (any no. of children) 746 (70.2%) 61 (30%) 144 (70.2%) 176 (80%) 172 (81.5%) 193 (86.6%)
Not workinga 341 (32.11%) 31 (15.27%) 34 (16.6%) 26 (11.82%) 66 (31.3%) 184 (82.5%)
Health care
Insurance status (public only) 151 (68%) 158 (78.6%) 141 (68.8%) 149 (68%) 136 (65%) 151 (68%)
Availability of GP (no GP) 155 (14.6%) 41 (20.2%) 35 (17.2%) 37 (16.9%) 30 (14.2%) 12 (5.4%)
Any CV medication 279 (26.27%) 7 (3.45%) 16 (7.8%) 51 (23.18%) 81 (38.39%) 124 (55.61%)
Any medical consultation within last 3 months 774 (73.2%) 141 (69.5%) 141 (69.1%) 162 (74%) 155 (73.8%) 175 (78.8%)
Risk factors
Smoking (active) 296 (28%) 72 (35.6%) 77 (37.6%) 68 (31.3%) 57 (27.1%) 22 (9.9%)
Diabetes mellitus 55 (5.2%) 0 7 (3.4%) 8 (3.7%) 11 (5.2%) 29 (13.2%)
Hypertension 281 (26.5%) 8 (4%) 18 (8.8%) 53 (24.2%) 80 (37.9%) 122 (54.7%)
Obesity (BMI >30) 168 (15.8%) 11 (5.4%) 28 (13.7%) 35 (15.9%) 43 (20.4%) 51 (22.9%)
(WHR >0.86) 265 (25%) 10 (4.9%) 38 (18.54%) 64 (29.1%) 64 (30.3%) 89 (39.9%)
Hyperlipidemia (Tot/HDL ratio) 142 (13.4%) 10 (4.9%) 31 (15.1%) 30 (13.6%) 40 (19%) 31 (13.9%)
Any family history (positive) 851 (80.3%) 164 (80.8%) 167 (81.5%) 184 (83.6%) 176 (83.4%) 160 (71.8%)
Previous CV event 27 (2.5%) 2 (1%) 1 (0.5%) 3 (1.4%) 8 (3.8%) 13 (5.8%)
Atrial fibrillation 3 (0.28%) 0 0 1 (0.45%) 0 2 (0.9%)
Autoimmune disease 125 (11.9%) 10 (4.95%) 22 (10.84%) 21 (9.68) 37 (17.87) 35 (15.84%)
Postmenopausal 534 (51.4%) 5 (2.5%) 20 (9.8%) 94 (43.12%) 206 (99.04%) 209 (100%)
Pregnancy complications 87 (8.19%) 6 (2.96%) 16 (7.8%) 15 (6.82%) 25 (11.85%) 25 (11.21%)
Depressive moodb (PHQ9≥ 15) 52 (5.2%) 10 (5.1%) 13 (6.63%) 14 (6.86%) 11 (5.47%) 4 (1.97%)
(PHQ9≥ 10) 168 (16.8%) 42 (21.4%) 34 (17.4%) 36 (17.6%) 32 (15.9%) 24 (11.8%)
aUnemployment or retirement; bBoth cutoffs were reported to allow for comparison with national and international surveys.













Table 2 Subjective estimation vs. Framingham score (stratified according to D’Agostino [24])
High Framingham score Medium Framingham score Low Framingham score
Risk estimate high 4.49% 4.69% 0.5%
(n = 45) (n = 47) (n = 5)
Risk estimate medium 16.85% 25.42% 4.79%
(n = 169) (n = 255) (n = 48)
Risk estimate low 6.78% 25.02 11.47%
(n = 68) (n = 251) (n = 115)
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their risk.
Lack of awareness of objective risk factors
Next to subjective awareness of cardiovascular risk, we
also evaluated the objective knowledge about risk factors
in the participant population. Women were asked whether
they knew optimal values of blood pressure, fasting
glucose, and cholesterol using multiple-choice questions
and to rate the importance of age as a risk factor on a
range from 1 to 10. All of these parameters displayed
trends for modification with increasing age. Knowledge of
ideal values of blood pressure (P <0.0001), cholesterol
(P <0.0001), and fasting glucose (P = 0.03) all increased
with age, probably due to an increase in relevance. In fact,
among the population of diabetics, 59.6% knew the ideal
values of fasting glucose, while only 27.8% of the non-
diabetics were aware of these numbers (P <0.0001). The
same applied for hypertension (88% among known hy-
pertensives vs. 79.6% in normotensives, P = 0.002) and
hyperlipidemia (36.6% among hyperlipidemics vs. 26.7%
non-hyperlipidemics, P = 0.03). As expected, job experi-
ence in the health care sector significantly correlated
with correct estimation of ideal blood pressure, fasting
glucose, and cholesterol (all P <0.0001), yet it did not
impact the perceived relevance of age as an important
risk factor (63.2% among health care experienced
individuals vs. 61.9% among the general population,
P = 0.69). Age was rated an important risk factor by
62.1% of the study population, yet this perception only
weakly increased with increasing age (P = 0.046). Over-
all, knowledge about objective risk parameters did not
significantly associate with correctness of estimation.Table 3 Multiple regression analysis of predictors for
subjective under- and overestimation of cardiovascular
risk: underestimation
OR 95% CI P
Age >50 years 3.5 2.6–4.8 <0.0001
Joblessness 1.9 1.4 –2.6 <0.0001
Social risk factors (3 or more) 1.5 1.1–2.1 0.009
Positive subjective health rating 1.7 1.2–2.3 0.003
Goodness-of-fit (Wald) n.s.; Hosmer-Lemeshow n.s.; ROC for prediction 0.71.Discussion
We designed this study to evaluate women’s estimation
of their subjective cardiovascular risk, as this appears to
be one of the potential causal factors on the path from
underestimation of cardiovascular relevance to cardio-
vascular mortality. To our knowledge, the BEFRI study
was the first attempt to elucidate these factors. First, we
could confirm that both typical cardiovascular risk fac-
tors as well as female-specific risk factors correlate with
age. Second, we discovered that subjective underestima-
tion of cardiovascular risk significantly rises with age
and the presence of three or more unfavorable social risk
factors. Third, we determined how consciousness of age
as a cardiovascular risk factor only minimally increases
with the age of the rating subject. Overall, this reveals
how women at increased risk are also the ones less
aware of their risk and, thus, identifies new challenges in
the development of future preventative measures.
Increasing age has been described as a cardiovascular risk
factor from the start of cardiovascular epidemiology [25].
The prevalence of atherosclerosis [26], metabolic dysfunc-
tion [27], and immune dysregulation [28] all increase with
age, resulting in an increased incidence of hypertension,
diabetes, dyslipidemia, and vascular dysfunction [29]. These
phenomena have been described in both sexes, although
the relevance of these risk factors is more prominent in
women compared to men [30]. The attention has only re-
cently shifted to the role of ‘female-specific’ risk factors,
such as pregnancy complications, autoimmune diseases,
and increased incidence of depressive and mood disorders,
as potential predisposing risks for cardiovascular events
[21,31], leading to the inclusion of gender and ethnicity asTable 4 Multiple regression analysis of predictors for
subjective under- and overestimation of cardiovascular
risk: overestimation
OR 95% CI P
Age >50 years 0.45 0.24–0.87 0.02
Negative Subjective Health Rating 2.7 1.4–5.1 0.002
Depression (PHQ ≥10) 2.2 1.2–4.0 0.014
Low income 0.48 0.28–0.84 0.009
Simple/Mid-level Job 0.59 0.41–0.83 0.003
Goodness-of-fit (Wald) n.s.; Hosmer-Lemeshow n.s.; ROC for prediction 0.75.
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which also includes the risk of experiencing a stroke [32].
Furthermore, recent reports of a potentially biphasic effect
of estrogens, not just as protectors against cardiovascular
risk factors, but also as potential accelerators under certain
circumstances, should be considered [33]. In our study, we
systematically assessed all these aspects in a representative
sample of an urban German population and confirmed that
classic risk factors linearly associate with age – rather than
precipitously increasing after menopause – and that this
also applies to most female-specific risk factors, although to
a less pronounced degree. In fact, pregnancy complications
experienced by the participants did increase with age, yet
the differences among the highest age band and the lowest
were about 10%. While this might be due to a reporting
bias, it also confirms a physiological decrease due to im-
provement of care over the last decades in a population
that had acceptable standards to begin with. Autoimmune
diseases display two hormone-associated incidence peaks,
during the fertile period of a woman’s life and after meno-
pause, yet different diseases display different associations
with hormonal status [34,35] and this might well explain a
progressive yet contained surge over time. However, one
should also consider that being a population study and not
a hospital-based investigation, a ‘healthy participant’ bias
might prevent women with significant disability to partici-
pate in the study. This will have inevitably excluded some
individuals from being captured with this sampling strategy,
albeit equally at all ages. The same probably also applies to
participants with depression. Prevalence of depression does
not vary significantly in the different age groups below
65 years of age, which is well in line with recent demog-
raphy studies of the German population [36]. In the study
population over 65 years of age, however, prevalence num-
bers decreased significantly. Since a real reduction in this
age group appears unlikely, this could be explained either
by the increased mortality in depressed patients, given the
association of depression with morbidity [37,38], or the
presence of other co-morbidities in association with depres-
sion that impeded participation in the study.
Although to physicians age is a well-documented risk
factor for any disease, the perception of this aspect in the
general female population and the consequent adaptation
of one’s subjective risk perception do not appear to follow.
Interpretation of the concept of subjective risk might also
have been skewed, yet, this phenomenon has been de-
scribed to various ends in the literature. In fact, both the
association between risk factors and perception [39] and
absence thereof have been described [40]. Some authors
also identified a variance in risk perception depending on
whether the question was asked in absolute or compara-
tive – to a group of peers – terms [41]. Interestingly, in
our population the older the women the more likely they
appeared to underestimate their subjective risk. However,this was not only a subjective underestimation, which has
been described before as ‘unrealistic optimism’ [42], but
an invariant perception of the role of age over time. Since
cardiovascular risk increases with age and comorbidities
over time, and this is reflected substantially in risk scores,
the simple unawareness of this phenomenon will lead to a
significant misclassification of one’s own risk. In addition
to the role of age, social risk factors appeared as major
predictors of underestimation.
Joblessness, due to either unemployment of retirement,
significantly coincided with underestimation – irrespective
of age. Most likely, the psychosocial benefits of work life
[43] affect both risk development and ability to estimate
subjective risk, possibly due to peer comparison. Absence
of the routine and social integration that work life
provides, directly affected risk perception. Other social
risk factors, such as limited education, means, lower job
opportunities, living alone, having children, and absence
of integrative insurance coverage, were associated with
underestimation only if combined in sets of three or more.
This might be well explained by the functioning welfare
state in Germany, which appears effective in subsidizing
single social inequities, and by the compensatory function
of some factors towards others. For instance, having chil-
dren is not a social risk factor if the subject is well edu-
cated and has a profitable job, yet, it does constitute an
additional risk factor if the individual is poorly educated
and earns a meager income.
Some aspects should, nonetheless, be taken into consid-
eration. The following study is a good representation of the
urban population of Berlin, yet it is probably much less rep-
resentative of rural areas in Germany or some other parts
of Europe. Even with little education, the exposure to infor-
mation within a large city differs significantly from rural
areas, leading to different flows of information and possibly
also disinformation. Women have been asked to voluntarily
participate in the study, introducing a selection bias, which
might have been reinforced by the payment of an incentive.
However, the population is a good representation of the city
as whole and the payment of an incentive was only com-
municated after consent to participation had been given,
thus both these aspects have been minimized. Furthermore,
awareness and knowledge have been asserted by a ques-
tionnaire and not by direct interviewing, allowing for a po-
tential bias in education and concentration for the duration
of the process. This was minimized through an extensive
piloting phase, where questionnaires were evaluated with a
heterogeneous population, and has been confirmed by the
very limited rate of missing answers to the questionnaire.
Finally, we chose the Framingham global cardiovascular
risk score for women, which might overestimate risks as
described in the past; while this was confirmed for the
Framingham risk score for coronary heart disease [44], it
has not been described for the global cardiovascular risk
Oertelt-Prigione et al. BMC Medicine  (2015) 13:52 Page 8 of 9score. Nonetheless, the possibility of overestimation has to
be taken into account and could potentially alter the rela-
tionship between subjective perception and objective meas-
ure, i.e., increase the reported underestimation of risk. Every
score has inherent advantages and disadvantages and com-
parisons are oftentimes difficult [45]; thus, we chose the
most validated one and the one specifically proposed in the
guidelines for cardiovascular prevention in women [21].
Conclusions
The present study is the first evaluation of women’s subject-
ive risk estimation demonstrating how the most vulnerable
individuals, the elderly, and the socially disadvantaged bear
the greatest risk of subjective underestimation. Since the ac-
ceptance and uptake of preventive measures is inherently
linked to the self-perception of relevance, this result leads
us to conclude that much needs to be done to improve our
population’s health literacy and risk awareness. It appears
that, despite the relevance of age being well known, the
transfer of this concept to one’s self is problematic. We urge
that this aspect be emphasized in risk counselling in pri-
mary and specialist care, but also be addressed through tar-
geted information campaigns.
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